1. Home
  2. SCPH

SCPH

scPharmaceuticals Inc.

Logo scPharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-18-2024 3:59pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

Founded: 2013 Country:
United States
United States
Employees: N/A City: BURLINGTON
Market Cap: 168.4M IPO Year: 2017
Target Price: $19.33 AVG Volume (30 days): 233.0K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.42 EPS Growth: N/A
52 Week Low/High: $4.63 - $12.75 Next Earning Date: 05-08-2024
Revenue: $13,593,000 Revenue Growth: N/A
Revenue Growth (this year): 200.22% Revenue Growth (next year): 144.31%

Share on Social Networks: